TY - JOUR
T1 - Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients
T2 - what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder?
AU - Baeza, Inmaculada
AU - de la Serna, Elena
AU - Mezquida, Gisela
AU - Cuesta, Manuel J.
AU - Vieta, Eduard
AU - Amoretti, Silvia
AU - Lobo, Antonio
AU - González-Pinto, Ana
AU - Díaz-Caneja, Covadonga M.
AU - Corripio, Iluminada
AU - Valli, Isabel
AU - Puig, Olga
AU - Mané, Anna
AU - Bioque, Miquel
AU - Ayora, Miriam
AU - Bernardo, Miquel
AU - Castro-Fornieles, Josefina
AU - García-Rizo, Clemente
AU - González-Díaz, Jairo
AU - de Matteis, Mario
AU - de Diego, Héctor
AU - Grasa, Eva
AU - Roldán, Alejandra
AU - Zorrilla, Iñaki
AU - García-Corres, Edurne
AU - Ruíz-Lázaro, Pedro M.
AU - de-la-Cámara, Concepción
AU - Rivero, Olga
AU - Escarti, María José
AU - Casanovas, Francesc
AU - Toll, Alba
AU - Verdolini, Norma
AU - Sagué-Vilabella, Maria
AU - Sugranyes, Gisela
AU - Ilzarbe, Daniel
AU - Contreras, Fernando
AU - González-Blanco, Leticia
AU - García-Portilla, María Paz
AU - Gutierrez, Miguel
AU - Zabala, Arantzazu
AU - Rodríguez-Jiménez, Roberto
AU - Sánchez-Pastor, Luis
AU - Usall, Judith
AU - Butjosa, Anna
AU - Pomarol, Edith
AU - Sarró, Salvador
AU - Ibáñez, Angela
AU - Sánchez-Torres, Ana Maria
AU - Balanzá-Martínez, Vicent
N1 - Funding Information:
The PEPs Study is a coordinated-multicentre project funded by the Ministerio de Economía y Competitividad (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III – Fondo Europeo de Desarrollo Regional. Unión Europea.“Una manera de hacer Europa”, cofinanciado por la Unión Europea, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, the CERCA Program / Generalitat de Catalunya and Secretaria d’Universitats i Recerca del Departament d’Economia I Coneixement (2017SGR1355, 2017SGR881). Departament de Salut de la Generalitat de Catalunya, Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2016-2020 (SLT006/17/00345). The authors would like to thank the patients and families who collaborated in the study, Mr. R. Borras for his statistical advice, and Mr. A.D. Pierce for his English editorial assistance. Previous presentations: Poster presented at the European College of Neuropsychopharmacology (ECNP) annual meeting, Barcelona, Spain, October 6-9, 2018. Oral communication presented at the XXI Spanish Psychiatry Conference (Congreso Nacional de Psiquiatría), Granada, España, October 18–20, 2018.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/4/7
Y1 - 2023/4/7
N2 - To assess the role of age (early onset psychosis-EOP < 18 years vs. adult onset psychosis-AOP) and diagnosis (schizophrenia spectrum disorders-SSD vs. bipolar disorders-BD) on the duration of untreated psychosis (DUP) and prodromal symptoms in a sample of patients with a first episode of psychosis. 331 patients with a first episode of psychosis (7–35 years old) were recruited and 174 (52.6%) diagnosed with SSD or BD at one-year follow-up through a multicenter longitudinal study. The Symptom Onset in Schizophrenia (SOS) inventory, the Positive and Negative Syndrome Scale and the structured clinical interviews for DSM-IV diagnoses were administered. Generalized linear models compared the main effects and group interaction. 273 AOP (25.2 ± 5.1 years; 66.5% male) and 58 EOP patients (15.5 ± 1.8 years; 70.7% male) were included. EOP patients had significantly more prodromal symptoms with a higher frequency of trouble with thinking, avolition and hallucinations than AOP patients, and significantly different median DUP (91 [33–177] vs. 58 [21–140] days; Z = − 2.006, p = 0.045). This was also significantly longer in SSD vs. BD patients (90 [31–155] vs. 30 [7–66] days; Z = − 2.916, p = 0.004) who, moreover had different profiles of prodromal symptoms. When assessing the interaction between age at onset (EOP/AOP) and type of diagnosis (SSD/BD), avolition was significantly higher (Wald statistic = 3.945; p = 0.047), in AOP patients with SSD compared to AOP BD patients (p = 0.004). Awareness of differences in length of DUP and prodromal symptoms in EOP vs. AOP and SSD vs. BD patients could help improve the early detection of psychosis among minors.
AB - To assess the role of age (early onset psychosis-EOP < 18 years vs. adult onset psychosis-AOP) and diagnosis (schizophrenia spectrum disorders-SSD vs. bipolar disorders-BD) on the duration of untreated psychosis (DUP) and prodromal symptoms in a sample of patients with a first episode of psychosis. 331 patients with a first episode of psychosis (7–35 years old) were recruited and 174 (52.6%) diagnosed with SSD or BD at one-year follow-up through a multicenter longitudinal study. The Symptom Onset in Schizophrenia (SOS) inventory, the Positive and Negative Syndrome Scale and the structured clinical interviews for DSM-IV diagnoses were administered. Generalized linear models compared the main effects and group interaction. 273 AOP (25.2 ± 5.1 years; 66.5% male) and 58 EOP patients (15.5 ± 1.8 years; 70.7% male) were included. EOP patients had significantly more prodromal symptoms with a higher frequency of trouble with thinking, avolition and hallucinations than AOP patients, and significantly different median DUP (91 [33–177] vs. 58 [21–140] days; Z = − 2.006, p = 0.045). This was also significantly longer in SSD vs. BD patients (90 [31–155] vs. 30 [7–66] days; Z = − 2.916, p = 0.004) who, moreover had different profiles of prodromal symptoms. When assessing the interaction between age at onset (EOP/AOP) and type of diagnosis (SSD/BD), avolition was significantly higher (Wald statistic = 3.945; p = 0.047), in AOP patients with SSD compared to AOP BD patients (p = 0.004). Awareness of differences in length of DUP and prodromal symptoms in EOP vs. AOP and SSD vs. BD patients could help improve the early detection of psychosis among minors.
UR - http://www.scopus.com/inward/record.url?scp=85152432138&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85152432138&partnerID=8YFLogxK
U2 - 10.1007/s00787-023-02196-7
DO - 10.1007/s00787-023-02196-7
M3 - Research Article
C2 - 37027026
AN - SCOPUS:85152432138
SN - 1018-8827
JO - European Child and Adolescent Psychiatry
JF - European Child and Adolescent Psychiatry
ER -